On the afternoon of June 21, 2018, 12 members of the Chinese Academy of Social Sciences visited our company. The vice president of the Institute, Dr. Zhiyong Li, led them during the visit to the institute and introduced the new products and the company's traditional heparin products to them. The leaders of CASS showed their approval of the company's hardware facilities and talent pool, and they paid great attention to the new drug-albenatide, which is a new product for the treatment of diabetes. They hoped that the product would be marketed as soon as possible to benefit diabetic patients. Xiuran Xu, Deputy Director of the Propaganda Department, and Shijun Cui, Director of the High-tech Zone Administration Committee, accompanied them in the visit.